title: MHC class I-associated peptides derive from selective regions of the human genome.
abstract: MHC class I-associated peptides (MAPs) define the immune self for CD8+ T lymphocytes and are key targets of cancer immunosurveillance. Here, the goals of our work were to determine whether the entire set of protein-coding genes could generate MAPs and whether specific features influence the ability of discrete genes to generate MAPs. Using proteogenomics, we have identified 25,270 MAPs isolated from the B lymphocytes of 18 individuals who collectively expressed 27 high-frequency HLA-A,B allotypes. The entire MAP repertoire presented by these 27 allotypes covered only 10% of the exomic sequences expressed in B lymphocytes. Indeed, 41% of expressed protein-coding genes generated no MAPs, while 59% of genes generated up to 64 MAPs, often derived from adjacent regions and presented by different allotypes. We next identified several features of transcripts and proteins associated with efficient MAP production. From these data, we built a logistic regression model that predicts with good accuracy whether a gene generates MAPs. Our results show preferential selection of MAPs from a limited repertoire of proteins with distinctive features. The notion that the MHC class I immunopeptidome presents only a small fraction of the protein-coding genome for monitoring by the immune system has profound implications in autoimmunity and cancer immunology.
authors.forename: Hillary
authors.initials: H
authors.lastname: Pearson
authors.forename: Tariq
authors.initials: T
authors.lastname: Daouda
authors.forename: Diana Paola
authors.initials: DP
authors.lastname: Granados
authors.forename: Chantal
authors.initials: C
authors.lastname: Durette
authors.forename: Eric
authors.initials: E
authors.lastname: Bonneil
authors.forename: Mathieu
authors.initials: M
authors.lastname: Courcelles
authors.forename: Anja
authors.initials: A
authors.lastname: Rodenbrock
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Laverdure
authors.forename: Caroline
authors.initials: C
authors.lastname: Côté
authors.forename: Sylvie
authors.initials: S
authors.lastname: Mader
authors.forename: Sébastien
authors.initials: S
authors.lastname: Lemieux
authors.forename: Pierre
authors.initials: P
authors.lastname: Thibault
authors.forename: Claude
authors.initials: C
authors.lastname: Perreault
mesh_terms: D001402:B-Lymphocytes / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D005260:Female; D015894:Genome, Human / Q000276:immunology*; D015234:HLA-A Antigens / Q000235:genetics / Q000276:immunology; D015235:HLA-B Antigens / Q000235:genetics / Q000276:immunology; D006801:Humans; D008297:Male; D010455:Peptides / Q000235:genetics / Q000276:immunology
chemical_list: D015234:HLA-A Antigens; D015235:HLA-B Antigens; D010455:Peptides